UKM inks MoA to advance cancer treatment


Meaningful collaboration: (from left) UKM Faculty of Medicine dean Prof Dr Abdul Halim Abdul Gafor, Prof Dr Wan Kamal, Dr Park, and NK Biocell medical director Dr Lan Leong Chung.

UNIVERSITI Kebangsaan Malaysia (UKM) is working towards advancing cancer treatment under a new collaboration with NK Biocell Sdn Bhd.

The memorandum of agreement (MoA), signed at Hospital Universiti Kebangsaan Malaysia (HUKM) recently, has the potential to offer hope for cancer patients in Malaysia who are seeking treatment other than chemotherapy.

Subscribe or renew your subscriptions to win prizes worth up to RM68,000!

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In Education

Experts: Making secondary education compulsory the right move
Poorer international assessment results due to online learning
TARC’s legacy in the limelight
Students craft eco-roof tiles from nature’s bounty
Floods: No need for second SPM session, says Education Minister
Over 40,000 kids getting special needs education
King issues stern warning to UPNM
‘12-year education a must’
Interventions for kids lacking basic literacy, numeracy skills
‘A beacon in the darkness’

Others Also Read